These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 29402328)

  • 1. Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
    Melucci E; Casini B; Ronchetti L; Pizzuti L; Sperati F; Pallocca M; De Nicola F; Goeman F; Gallo E; Amoreo CA; Sergi D; Terrenato I; Vici P; Di Lauro L; Diodoro MG; Pescarmona E; Barba M; Mazzotta M; Mottolese M; Fanciulli M; Ciliberto G; De Maria R; Buglioni S; Maugeri-Saccà M
    J Transl Med; 2018 Feb; 16(1):22. PubMed ID: 29402328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer.
    Di Benedetto A; Mottolese M; Sperati F; Ercolani C; Di Lauro L; Pizzuti L; Vici P; Terrenato I; Sperduti I; Shaaban AM; Sundara-Rajan S; Barba M; Speirs V; De Maria R; Maugeri-Saccà M
    Oncotarget; 2016 Jul; 7(28):43188-43198. PubMed ID: 27248471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer.
    Pallocca M; Goeman F; De Nicola F; Melucci E; Sperati F; Terrenato I; Pizzuti L; Casini B; Gallo E; Amoreo CA; Vici P; Di Lauro L; Buglioni S; Diodoro MG; Pescarmona E; Mazzotta M; Barba M; Fanciulli M; De Maria R; Ciliberto G; Maugeri-Saccà M
    J Transl Med; 2018 Sep; 16(1):247. PubMed ID: 30180862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer.
    Di Benedetto A; Mottolese M; Sperati F; Ercolani C; Di Lauro L; Pizzuti L; Vici P; Terrenato I; Shaaban AM; Humphries MP; Sundara-Rajan S; Barba M; Speirs V; De Maria R; Maugeri-Saccà M
    J Cell Physiol; 2017 Aug; 232(8):2246-2252. PubMed ID: 27987320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy.
    Vici P; Ercolani C; Di Benedetto A; Pizzuti L; Di Lauro L; Sperati F; Terrenato I; Gamucci T; Natoli C; Di Filippo F; Botti C; Barba M; Mottolese M; De Maria R; Maugeri-Saccà M
    J Exp Clin Cancer Res; 2016 Apr; 35():62. PubMed ID: 27039292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of TAZ indicates a poor prognosis in retinoblastoma.
    Zhang Y; Xue C; Cui H; Huang Z
    Diagn Pathol; 2015 Oct; 10():187. PubMed ID: 26464030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential requirement of Hippo cascade during CTNNB1 or AXIN1 mutation-driven hepatocarcinogenesis.
    Liang B; Wang H; Qiao Y; Wang X; Qian M; Song X; Zhou Y; Zhang Y; Shang R; Che L; Chen Y; Huang Z; Wu H; Monga SP; Zeng Y; Calvisi DF; Chen X; Chen X
    Hepatology; 2023 Jun; 77(6):1929-1942. PubMed ID: 35921500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment.
    Buglioni S; Vici P; Sergi D; Pizzuti L; Di Lauro L; Antoniani B; Sperati F; Terrenato I; Carosi M; Gamucci T; Vincenzoni C; Mariani L; Vizza E; Venuti A; Sanguineti G; Gadducci A; Barba M; Natoli C; Vitale I; Mottolese M; De Maria R; Maugeri-Saccà M
    Oncoimmunology; 2016 Jun; 5(6):e1160187. PubMed ID: 27471633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of CD11c indicates favorable prognosis in patients with gastric cancer.
    Wang Y; Xu B; Hu WW; Chen LJ; Wu CP; Lu BF; Shen YP; Jiang JT
    World J Gastroenterol; 2015 Aug; 21(31):9403-12. PubMed ID: 26309367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep sequencing and pathway-focused analysis revealed multigene oncodriver signatures predicting survival outcomes in advanced colorectal cancer.
    De Nicola F; Goeman F; Pallocca M; Sperati F; Pizzuti L; Melucci E; Casini B; Amoreo CA; Gallo E; Diodoro MG; Buglioni S; Mazzotta M; Vici P; Sergi D; Di Lauro L; Barba M; Pescarmona E; Ciliberto G; De Maria R; Fanciulli M; Maugeri-Saccà M
    Oncogenesis; 2018 Jul; 7(7):55. PubMed ID: 30032163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.
    Wei Z; Wang Y; Li Z; Yuan C; Zhang W; Wang D; Ye J; Jiang H; Wu Y; Cheng J
    J Oral Pathol Med; 2013 Nov; 42(10):747-54. PubMed ID: 23551691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LKB1 inhibits the proliferation of gastric cancer cells by suppressing the nuclear translocation of Yap and β-catenin.
    Ma LG; Bian SB; Cui JX; Xi HQ; Zhang KC; Qin HZ; Zhu XM; Chen L
    Int J Mol Med; 2016 Apr; 37(4):1039-48. PubMed ID: 26936013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAZ is an independent prognostic factor in non-small cell lung carcinoma: Elucidation at protein level.
    Malik SA; Khan MS; Dar M; Hussain MU; Mudassar S
    Cancer Biomark; 2017; 18(4):389-395. PubMed ID: 28128737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
    Ronchetti L; Melucci E; De Nicola F; Goeman F; Casini B; Sperati F; Pallocca M; Terrenato I; Pizzuti L; Vici P; Sergi D; Di Lauro L; Amoreo CA; Gallo E; Diodoro MG; Pescarmona E; Vitale I; Barba M; Buglioni S; Mottolese M; Fanciulli M; De Maria R; Maugeri-Saccà M
    Int J Cancer; 2017 Jun; 140(11):2587-2595. PubMed ID: 28233295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes.
    Di Benedetto A; Mottolese M; Sperati F; Ercolani C; Di Lauro L; Pizzuti L; Vici P; Terrenato I; Shaaban AM; Sundara-Rajan S; Humphries MP; Barba M; Speirs V; De Maria R; Maugeri-Saccà M
    Sci Rep; 2016 Oct; 6():35121. PubMed ID: 27713571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction.
    Sun L; Chen F; Shi W; Qi L; Zhao Z; Zhang J
    Diagn Pathol; 2014 Jul; 9():125. PubMed ID: 25029906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt/β-Catenin and Hippo Pathway Deregulation in Mammary Tumors of Humans, Dogs, and Cats.
    Sammarco A; Gomiero C; Sacchetto R; Beffagna G; Michieletto S; Orvieto E; Cavicchioli L; Gelain ME; Ferro S; Patruno M; Zappulli V
    Vet Pathol; 2020 Nov; 57(6):774-790. PubMed ID: 32807036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hippo Signaling Core Components YAP and TAZ as New Prognostic Factors in Lung Cancer.
    Jiang Y; Xie WJ; Chen RW; You WW; Ye WL; Chen H; Chen WX; Xu JP
    Front Surg; 2022; 9():813123. PubMed ID: 35388363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of tumoral FOXP3 in gastric adenocarcinoma is associated with favorable clinicopathological variables and related with Hippo pathway.
    Suh JH; Won KY; Kim GY; Bae GE; Lim SJ; Sung JY; Park YK; Kim YW; Lee J
    Int J Clin Exp Pathol; 2015; 8(11):14608-18. PubMed ID: 26823784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
    Li X; Pasche B; Zhang W; Chen K
    JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.